GPT and fibrosis: In the stratified analyses, we found that the AST/ALT ratio was associated with adverse 90-day outcomes in the patients with advanced fibrosis with an INR of ≥1.5, or a TBIL level of >10 mg/dL, or an HBV infection {Figure 2A; INR of ≥1.5: odds ratio [OR] = 1.530 (95% CI = 1.129–2.074), p = 0.006; TBIL level of ≥10 mg/dL: OR = 1.437 (95% CI = 1.090–1.894), p = 0.010; HBV infection: OR = 1.657 (95% CI = 1.181–2.325), p = 0.003}.